Please ensure Javascript is enabled for purposes of website accessibility

3 Popular Robinhood Stocks That Could Be Better Than Bitcoin in 2021

By Keith Speights - Jan 28, 2021 at 6:04AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

None of them outperformed the cryptocurrency in 2020, but that could change this year.

It's been a rollercoaster ride for bitcoin already in 2021, and the year is still young.

However, I wouldn't be surprised if bitcoin delivers solid returns over the next 11 months. On the other hand, I also think that Robinhood investors like several stocks that could generate even higher returns. Here are three popular stocks on the no-cost trading platform that could be better than bitcoin in 2021.

Coin with the bitcoin symbol on it with a stock chart in the background

Image source: Getty Images.

1. ARK Innovation ETF

OK, ARK Innovation ETF (ARKK 1.46%) really isn't a stock. It's an exchange-traded fund (ETF) that trades like a stock, though. It's also beloved by Robinhood investors. I think ARKK deserves its acclaim. In fact, my view is that ARKK ranks as the popular Robinhood stock most likely to soar in 2021.

ARKK was a big winner last year with a return of 149%. While that didn't outperform bitcoin, I think the story could change going forward. 

For one thing, ARKK has Cathie Wood at the helm. She's without question one of the most accomplished investors on the scene today. With this particular ETF, Wood has a special opportunity to shine as she focuses on the stocks of companies with tremendous disruptive potential.

We could talk about plenty of ARKK's holdings that should generate huge gains this year, but I'll only highlight two of them. I think Roku and Square will benefit from two unstoppable trends -- connected TV and digital payments, respectively. ARKK also has dozens of other great stocks that could also help it outperform bitcoin in 2021.

2. Hexo

Some might think that 2021 will be a banner year for cryptocurrencies. I suspect that it will be an even bigger year for marijuana stocks. If I'm right, that could bode well for Robinhood favorite Hexo (HEXO 8.72%).

Granted, Hexo looked like anything but a stock you'd want to own last year. Its shares plunged 42%. However, steep declines were common among Canadian pot stocks. But things are definitely looking up now.

Don't be surprised if the Democratic-controlled U.S. Congress moves forward this year with legislation that decriminalizes marijuana. If such a bill passes and is signed into law by President Biden, it could clear the way for Hexo to enter the lucrative U.S. cannabis market while retaining its listing on the New York Stock Exchange. 

Hexo is already in the U.S. market in one way. Truss CBD USA, a joint venture formed by Hexo and its big partner Molson Coors, began marketing nonalcoholic CBD-infused beverages in Colorado earlier this month. I think that cannabis reform at the federal level could open up a much greater opportunity for Hexo (perhaps with Molson Coors at its side) and make this beaten-down pot stock beat bitcoin this year.

3. Inovio Pharmaceuticals

Perhaps the most critical milestone for the world this year will be the massive rollouts of COVID-19 vaccines. The vaccine developed by Inovio Pharmaceuticals (INO -0.42%) could be among those administered in 2021. 

Inovio turned in a tremendous performance last year, with its shares soaring 168%. That gain could be a drop in the bucket, though, if the biotech's INO-4800 COVID-19 vaccine proves safe and highly effective.

It will be later in the year before we know more about the real potential for INO-4800. Inovio is currently evaluating the experimental vaccine in a phase 2 clinical study. 

The biotech stock could have another major catalyst on the way, though. Inovio expects to report results from a late-stage study of VGX-3100 in treating precancerous cervical dysplasia in the first half of 2021. Positive results from this study could set the stage for a regulatory filing for VGX-3100.

An important disclaimer

Can these three stocks really outgain bitcoin this year? I think so. However, there's no way to be sure that will happen. While I like ARKK, I'm not recommending either Hexo or Inovio at this point.

My view is that there are even better marijuana stocks than Hexo that Robinhood investors can't buy. The trading platform restricts access to most over-the-counter (OTC) stocks. Currently, all of the U.S.-based multistate cannabis operators can't list their shares on major U.S. exchanges and are only available on OTC markets. I also think that although Inovio's INO-4800 has potential, there are more attractive COVID-19 vaccine stocks to buy.

These popular Robinhood stocks could be better than bitcoin -- but there are other stocks that could be better than them.

Keith Speights owns shares of Square but has no position in other stocks or any cryptocurrencies mentioned. The Motley Fool owns shares of and recommends Roku and Square. The Motley Fool recommends HEXO. The Motley Fool does not own any of the cryptocurrencies mentioned. The Motley Fool has a disclosure policy.


Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Inovio Pharmaceuticals, Inc. Stock Quote
Inovio Pharmaceuticals, Inc.
$2.36 (-0.42%) $0.01
ARK ETF Trust - ARK Innovation ETF Stock Quote
ARK ETF Trust - ARK Innovation ETF
$50.80 (1.46%) $0.73
HEXO Stock Quote
$0.22 (8.72%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.